© Japanese Cancer Association
Edited By: Yusuke Nakamura
Impact Factor: 3.896
ISI Journal Citation Reports © Ranking: 2015: 62/213 (Oncology)
Online ISSN: 1349-7006
Recently Published Issues
Download the Free App on your iPhone/iPad or Android today!
All articles published by Cancer Science are freely available to read, download and share. To cover the cost of publishing, a publication fee will be charged. Please refer to the article publication charges page for more details.
For inquires, contact CancerScience@wiley.com.
Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression
Takuya Hattori, Kazuhiro Sentani, et al.
NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis
Shenghu Feng, Ming Han, et al.
Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors
Hirokazu Taniguchi, Shinji Takeuchi, et al.
EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway
Akifumi Endo, Daisuke Tomizawa, et al.
Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine
Masafumi Ikeda, Akihiro Sato, et al.
CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance
Hiroyuki Minemura, Kiyoshi Takagi, et al.
Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2
Fumihiko Kakizaki, Masahiro Sonoshita, et al.
Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
Nobuaki Fukushima, Yosuke Minami, et al.
IL-17A-producing CD30+ Vδ1 T cells drive inflammation-induced cancer progression
Yoshitaka Kimura, Nao Nagai, et al.
Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway
Afzal Sheikh, Atsushi Takatori, et al.
New mouse model of acute adult T-cell leukemia generated by transplantation of AKT, BCLxL, and HBZ-transduced T cells
Yumiko Kasugai, Noriaki Yoshida, et al.
Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism
Yutaka Fujiwara, Akinobu Hamada, et al.
Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer
Yaxiong Cai, Jinxia Zhang, et al.
C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility
Yoshie Senda, Naoko Murata-Kamiya, et al.
Myasthenic crisis and polymyositis induced by one dose of nivolumab
Toshihiro Kimura, Satoshi Fukushima, et al.
Negative influence of programmed death-1-ligands on the survival of esophageal cancer patients treated with chemotherapy
Koji Tanaka, Hiroshi Miyata, et al.
Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells
Issei Ezawa, Yuichiro Sawai, et al.
Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma
Chaoya Ma, Yoshihiro Komohara, et al.
Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma
Hidehiko Takigawa, Yasuhiko Kitadai, et al.
SERPINI1 regulates epithelial–mesenchymal transition in an orthotopic implantation model of colorectal cancer
Yasufumi Matsuda, Koh Miura, et al.
MicroRNA-761 is upregulated in hepatocellular carcinoma and regulates tumorigenesis by targeting mitofusin-2
Xiaohu Zhou, Linshi Zhang, et al.
Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer
Yumiko Kiyohara, Kiyoshi Yoshino, et al.
Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis
Yue Wang, Yasumasa Okazaki, et al.
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura, Sho Shiino, et al.
RAP80 regulates epithelial–mesenchymal transition related with metastasis and malignancy of cancer
Song Yi Park, Sovannarith Korm, et al.
Role for Daple in non-canonical Wnt signaling during gastric cancer invasion and metastasis
Hosne Ara, Maki Takagishi, et al.
Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis
Ki Mo Kim, A-Rang Im, et al.
Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations
Ken Suzawa, Shinichi Toyooka, et al.
Click below to access "In this Issue", introducing three highlight articles from each issue.
January 2017 highlights
December 2016 highlights
November 2016 highlights
October 2016 highlights
September 2016 highlights
August 2016 highlights
July 2016 highlights
June 2016 highlights
May 2016 highlights
April 2016 highlights
March 2016 highlights
February 2016 highlights
Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex
Okio Hino and Toshiyuki Kobayashi
Cancer stem cells in human gastrointestinal cancer
Hiroaki Taniguchi, Chiharu Moriya, et al.
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies
Yoichi Imai, Yoshiro Maru, et al.
Multiple facets of p53 in senescence induction and maintenance
Yoshikazu Johmura and Makoto Nakanishi
Application of glycoscience to the early detection of pancreatic cancer
Eiji Miyoshi and Yoshihiro Kamada
Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy
Takahiro Domoto, Ilya V. Pyko, et al.
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara, Yasushi Ino, et al.
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
Soochi Kim, Boyun Kim, et al.
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy
Yoshihisa Kobayashi and Tetsuya Mitsudomi
Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells
Shinjiro Hino, Kensaku Kohrogi, et al.
Lymphocyte-activation gene-3, an important immune checkpoint in cancer
Yayi He, Christopher J. Rivard, et al.
Development of polymeric micelles for targeting intractable cancers
Nobuhiro Nishiyama, Yasuhiro Matsumura, et al.
To wake up cancer stem cells, or to let them sleep, that is the question
Shoichiro Takeishi and Keiichi I. Nakayama
Gene aberrations for precision medicine against lung adenocarcinoma
Motonobu Saito, Kouya Shiraishi, et al.
Genetic abnormalities associated with acute lymphoblastic leukemia
Takafumi Yokota and Yuzuru Kanakura
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
Norihiro Sato, Shiro Kohi, et al.
The Wnt7's Tale: A story of an orphan who finds her tie to a famous family
Makoto Noda, Mario Vallon, et al.
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
Guo-Hao Huang, Qing-Fu Xu, et al.
TOP cited articles published in 2015-2016 from Cancer Science
TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma
Heng Xiao, Ning Jiang, et al.
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
Keishi Adachi and Koji Tamada
Therapeutic strategies targeting cancer stem cells
Go J. Yoshida and Hideyuki Saya
Recent advances in the treatment of adult T-cell leukemia-lymphomas
Atae Utsunomiya, Ilseung Choi, et al.
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer
Akira Kurozumi, Yusuke Goto, et al.
Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells
Chunyang Wang, Weiyang Tao, et al.
Exosomes in development, metastasis and drug resistance of breast cancer
Dan-dan Yu, Ying Wu, et al.
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose
Hirotsugu Kenmotsu and Yusuke Tanigawara